Qube Research & Technologies LTD Artivion, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Artivion, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 21,262 shares of AORT stock, worth $621,063. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,262Holding current value
$621,063% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding AORT
# of Institutions
174Shares Held
35.8MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$194 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$81.9 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$81.6 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$80.2 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$71.6 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.18B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...